280.08
Bio Rad Laboratories Inc 주식(BIO)의 최신 뉴스
Bay Area biotech giant Bio-Rad to lay off hundreds after $1.8 billion loss - MSN
Bio-Rad Laboratories Updates on Sartorius Investment - TipRanks
Biosensors Market Generated Opportunities, Future Scope - openPR
Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2025: Key Trends, Major Players, Opportunities, Strategies, M&As, 2018-2023, 2028F, 2033F - GlobeNewswire Inc.
Strategic Financial Concepts LLC Buys New Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Principal Securities Inc. Raises Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Bio-Rad Laboratories (NYSE:BIO) Stock Rating Lowered by StockNews.com - MarketBeat
Global Rapid Microbiology Testing Market to Reach $10.62 - openPR
Empowered Funds LLC Makes New $443,000 Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
BIO Stock Might Rise Following the Offer to Acquire Stilla - MSN
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2024 Earnings Call Transcript - MSN
Bio-Rad sued by Caltech over DNA analysis technology - Reuters
Surface Plasmon Resonance Market Future Business - openPR
Bio-Rad's M&A ambitions continue with Stilla buyout - BioProcess Insider
Is There An Opportunity With Bio-Rad Laboratories, Inc.'s (NYSE:BIO) 39% Undervaluation? - Simply Wall St
Bio-Rad Laboratories (NYSE:BIO) Sees Large Volume Increase After Better-Than-Expected Earnings - MarketBeat
Bio-Rad Laboratories (NYSE:BIO) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Allspring Global Investments Holdings LLC Decreases Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Releases Quarterly Earnings Results - MarketBeat
Next Generation Sequencing NGS Market is Projected to Achieve - openPR
DNA Extraction Kits Market Poised for Significant Growth | Key - openPR
Van ECK Associates Corp Has $237.67 Million Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Bio-Rad set to acquire Stilla Technologies - MSN
Immuno-Oncology Assays Market Projected To Witness Substantial Growth, 2025-2032:Sartorius AG, Bio-Rad - EIN News
Chromatography Data System Market to Experience Booming Growth - openPR
Bio-Rad targets 1.5%-3.5% revenue growth in 2025 amid operational improvements and new acquisitions - MSN
Sumitomo Mitsui Trust Group Inc. Has $11.96 Million Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Genomics Market Future Business Opportunities 2025-2032 | - openPR
Wells Fargo & Company Has Lowered Expectations for Bio-Rad Laboratories (NYSE:BIO) Stock Price - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownWhat's Next? - MarketBeat
Bio-Rad price target lowered to $447 from $477 at RBC Capital - Yahoo Finance
Bio-Rad Labs stock down 4% as Q4 revenue and guidance miss expectations - MSN
Bio-Rad Laboratories (NYSE:BIO) Shares Down 4.2%Here's Why - MarketBeat
Oncocyte secures $29.1 million to advance FDA assay - MSN
Bio-Rad Laboratories (BIO) Misses Q4 Earnings and Revenue Estimates - MSN
BIO-RAD LABORATORIES, INC. SEC 10-K Report - TradingView
Earnings call transcript: Bio-Rad Q4 2024 results miss forecasts - MSN
Bay Area biotech giant to lay off hundreds after $1.8 billion loss - SFGATE
BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket - Yahoo Finance
Bio-Rad Earnings: In-Line Results, Guidance Slightly Below Expectations, Shares Undervalued - Morningstar
Bio-Rad's Expanding Profit Margins and Stake in Sartorius Drive Long-Term Value - Morningstar
Entropy Technologies LP Reduces Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Earnings call transcript: Bio-Rad Q4 2024 results miss forecasts By Investing.com - Investing.com Nigeria
Enzyme Linked Immunosorbent Assay Market Growth, Share, - openPR
Bio-Rad Laboratories Inc (BIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Bio-Rad Laboratories Inc (BIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
자본화:
|
볼륨(24시간):